North America Indwelling Peripheral Intravenous Catheter Market size was valued at USD 0.8 Billion in 2022 and is projected to reach USD 1.3 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
The North American Indwelling Peripheral Intravenous Catheter (PIVC) market is segmented by application into various healthcare settings, including hospitals and clinics, ambulatory surgery centers, homecare settings, and others. Each of these subsegments plays a crucial role in the adoption and use of these devices, which are essential for administering medications, fluids, and nutrients to patients. The Indwelling Peripheral Intravenous Catheter is a preferred choice for intravenous (IV) access due to its ease of use and relatively low complication rate. These devices are integral to modern medical practice across multiple healthcare environments, where they offer convenience, flexibility, and critical care support.
Hospitals and clinics are the largest application segment for the Indwelling Peripheral Intravenous Catheter market. These facilities, ranging from large teaching hospitals to community clinics, require a high volume of intravenous procedures to manage patients with diverse medical conditions. PIVCs are commonly used for fluid and medication administration in emergency departments, surgical units, intensive care units (ICUs), and oncology departments. The increasing patient load in hospitals, particularly due to the rising incidence of chronic diseases, cancer treatments, and surgical procedures, continues to drive the demand for indwelling PIVCs in these settings. Additionally, the growing emphasis on reducing patient hospital stays and improving patient comfort and safety has further fueled the preference for PIVCs in hospitals and clinics.
Ambulatory Surgery Centres (ASCs) are becoming increasingly significant in the North American Indwelling Peripheral Intravenous Catheter market. ASCs are specialized facilities designed for the performance of outpatient surgical procedures. As outpatient surgeries continue to rise, the demand for PIVCs in ASCs has increased due to their ability to facilitate quick and effective intravenous access. PIVCs are often used in procedures that require sedation or the administration of anesthesia, such as cataract surgeries, orthopedic surgeries, and gastrointestinal procedures. ASCs prioritize patient comfort, minimal downtime, and efficient recovery, all of which are supported by the use of indwelling PIVCs, making them a critical component in enhancing patient outcomes and operational efficiency in outpatient settings.
The growing trend toward same-day discharge and minimally invasive surgeries in ASCs has propelled the adoption of PIVCs. Moreover, advancements in catheter technology, such as improved designs that reduce the risk of infection and enhance patient comfort, are expected to further bolster market growth in this segment. The preference for PIVCs over traditional methods like peripheral IV lines is driven by their ability to reduce complications, lower the need for repeated venipunctures, and promote faster recovery, making them an ideal solution for ASC environments where patient throughput and satisfaction are key priorities.
The homecare setting represents a rapidly growing application segment in the North American Indwelling Peripheral Intravenous Catheter market. With the increasing shift towards home-based healthcare, driven by factors such as cost containment, patient preference for home treatment, and advancements in medical technology, PIVCs are gaining traction for use in homecare settings. Many patients who require long-term intravenous therapy, such as those receiving chemotherapy, antibiotics, or nutrition support, now receive treatment at home. Indwelling PIVCs allow patients to undergo prolonged therapy in the comfort of their own homes, significantly improving quality of life while minimizing hospital readmissions.
In homecare, the use of PIVCs offers numerous benefits, including reduced infection risks, convenience, and enhanced mobility. The devices are particularly important for patients who require continuous intravenous access over extended periods, as they reduce the frequency of catheter replacement and minimize the discomfort and anxiety often associated with multiple needle insertions. The growing number of patients with chronic conditions, such as diabetes, heart disease, and cancer, is expected to further propel the adoption of PIVCs in homecare settings, where managing intravenous therapies in a non-clinical environment requires the expertise of trained healthcare professionals and reliable catheter systems.
The "Others" segment in the North American Indwelling Peripheral Intravenous Catheter market includes various niche applications outside of hospitals, clinics, ambulatory surgery centers, and homecare settings. These applications may involve specialized care facilities, such as long-term care institutions, rehabilitation centers, or certain research settings. While these markets are relatively smaller in comparison to the primary healthcare settings, they still present opportunities for the growth of PIVC usage. For example, in long-term care institutions, PIVCs are employed to manage the intravenous needs of elderly patients with chronic conditions or those requiring hospice care. In rehabilitation centers, these catheters are used to support intravenous therapy for patients recovering from serious injuries or surgeries.
The demand for indwelling PIVCs in other settings is fueled by the growing recognition of their role in enhancing patient outcomes and minimizing complications. As healthcare settings continue to evolve, with a greater emphasis on patient-centered care and cost-effectiveness, the versatility of PIVCs in specialized environments is expected to increase. Moreover, innovations in catheter design and materials are expected to drive further adoption of PIVCs across various niche segments. This makes the "Others" category a valuable, albeit smaller, portion of the market for indwelling peripheral intravenous catheters.
Download In depth Research Report of Indwelling Peripheral Intravenous Catheter Market
The top companies in the Indwelling Peripheral Intravenous Catheter market are leaders in innovation, growth, and operational excellence. These industry giants have built strong reputations by offering cutting-edge products and services, establishing a global presence, and maintaining a competitive edge through strategic investments in technology, research, and development. They excel in delivering high-quality solutions tailored to meet the ever-evolving needs of their customers, often setting industry standards. These companies are recognized for their ability to adapt to market trends, leverage data insights, and cultivate strong customer relationships. Through consistent performance, they have earned a solid market share, positioning themselves as key players in the sector. Moreover, their commitment to sustainability, ethical business practices, and social responsibility further enhances their appeal to investors, consumers, and employees alike. As the market continues to evolve, these top companies are expected to maintain their dominance through continued innovation and expansion into new markets.
Becton
Dickinson and Company
B. Braun
Smiths Group
Terumo Corporation
Venner Medical
Vygon
Teleflex
NIPRO Medical
Argon Medical Devices
ICU Medical
VOGT Medical
RenovoRx
Retractable Technologies
Merit Medical Systems
Cook Group
The North American Indwelling Peripheral Intravenous Catheter market is a dynamic and rapidly evolving sector, driven by strong demand, technological advancements, and increasing consumer preferences. The region boasts a well-established infrastructure, making it a key hub for innovation and market growth. The U.S. and Canada lead the market, with major players investing in research, development, and strategic partnerships to stay competitive. Factors such as favorable government policies, growing consumer awareness, and rising disposable incomes contribute to the market's expansion. The region also benefits from a robust supply chain, advanced logistics, and access to cutting-edge technology. However, challenges like market saturation and evolving regulatory frameworks may impact growth. Overall, North America remains a dominant force, offering significant opportunities for companies to innovate and capture market share.
North America (United States, Canada, and Mexico, etc.)
For More Information or Query, Visit @ Indwelling Peripheral Intravenous Catheter Market Size And Forecast 2024-2030
The North American Indwelling Peripheral Intravenous Catheter market is witnessing several key trends that are shaping its growth trajectory. One of the prominent trends is the increasing adoption of advanced catheter technologies, such as anti-microbial coated catheters and catheter lock solutions, aimed at reducing the risk of catheter-related infections (CRIs) and improving patient outcomes. The development of more patient-friendly catheter designs, including those with longer dwell times and improved comfort, is also expected to contribute to market growth. These innovations are making PIVCs a more attractive choice in both hospital and homecare settings, leading to greater market penetration.
Another significant trend is the rise in home healthcare, driven by an aging population and increasing preference for care at home. As more patients require intravenous therapies outside of traditional healthcare facilities, the demand for PIVCs is expected to rise in homecare settings. This trend presents ample investment opportunities for companies focusing on improving catheter reliability and ease of use for non-professional caregivers. Additionally, increasing government investments in healthcare infrastructure, particularly in rural areas, is expected to further expand the market for PIVCs in underserved regions. Companies that can address the growing demand for cost-effective, safe, and user-friendly catheter solutions are well-positioned to capitalize on these opportunities.
1. What is an Indwelling Peripheral Intravenous Catheter (PIVC)?
An Indwelling Peripheral Intravenous Catheter is a medical device used to administer intravenous fluids, medications, or nutrition. It is inserted into a vein and can remain in place for extended periods.
2. How long can an Indwelling Peripheral Intravenous Catheter stay in place?
Depending on the type of catheter and the patient's condition, PIVCs can stay in place for several days to weeks, though regular monitoring is essential to avoid complications.
3. What are the risks associated with Indwelling Peripheral Intravenous Catheters?
Risks include infection, phlebitis, and catheter occlusion, which can be mitigated through proper insertion techniques, care, and regular monitoring.
4. What is driving the growth of the Indwelling Peripheral Intravenous Catheter market in North America?
The growth is driven by factors such as the increasing demand for homecare services, technological advancements in catheter design, and the growing volume of outpatient and inpatient surgeries.
5. What are the key trends in the North American Indwelling Peripheral Intravenous Catheter market?
Key trends include the development of antimicrobial catheters, the rise of home healthcare, and innovations aimed at improving patient comfort and reducing infection risks.